BioSpace News Archive

ProMIS Neurosciences Lead Product Candidate for Alzheimer’s Disease, PMN310, Shows Potential for Improved Safety Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies

Lack of PMN310 binding to perivascular amyloid plaque in Alzheimer’s brain tissue may eliminate dose-limiting brain swelling seen with aducanumab.

January 4, 2018
·
4 min read
BioMidwest

Monsanto Spotlights Research & Development Pipeline Projects to Help Farmers Combat Threats, Optimize Opportunities and Conserve Natural Resources

This marks the fifth consecutive year that more than 20 projects advanced in the pipeline.

January 4, 2018
·
12 min read
German Biotech BioNTech Locks in $270M Series A

The Company previously completed a seed round fundraising in 2008 concurrent with its founding.

January 4, 2018
·
2 min read